| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Dimethylarginine| 1 | 2007 | Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. | 
| + | - | nl | Am J Physiol Heart Circ Physiol 293(6):H3227-45 (2007) |
| 2 | 2004 | Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway. |
| + | - | nl | Arterioscler Thromb Vasc Biol 24(6):1023-30 (2004) |
| 3 | 2004 | Asymmetrical dimethylarginine: the Uber marker? |
| + | - | nl | Circulation 109(15):1813-8 (2004) |
| 4 | 2005 | Asymmetric dimethylarginine and kidney disease--marker or mediator? |
| + | - | nl | J Am Soc Nephrol 16(8):2254-6 (2005) Vallance P |
| 5 | 2006 | Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis. |
| + | - | nl | Nephrol Dial Transplant 21(9):2446-51 (2006) |
| 6 | 2001 | ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease? |
| + | - | nl | Nephrol Dial Transplant 16(9):1742-5 (2001) |
